Giovanni Cecere - 14 Mar 2025 Form 3/A - Amendment Insider Report for TransMedics Group, Inc. (TMDX)

Role
Chief Commercial Officer
Signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
14 Mar 2025
Net transactions value
$0
Form type
3/A - Amendment
Filing time
20 Feb 2026, 16:05:09 UTC
Date Of Original Report
12 Feb 2026
Next filing
12 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cecere Giovanni Chief Commercial Officer C/O TRANSMEDICS GROUP, INC., 200 MINUTEMAN ROAD, ANDOVER By: /s/ Gerardo Hernandez, Attorney-in-Fact 20 Feb 2026 0002110539

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TMDX Common Stock 7,975 14 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 7,975 restricted share units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Remarks:

This filing is amended to include 7,975 shares in order to correct the inadvertent underreporting of shares held when the Form 3 was filed.